ipo
Stage
1
Investors
About
HLS Therapeutics is a specialty pharmaceutical company that manages a portfolio of commercial-stage branded medicines (e.g., clozapine and icosapent ethyl). The company sources products from originators and manufacturing partners and focuses on regulatory compliance and reliable market access in North America.
Explore HLS Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.